The Bloomberg School's Durbin recalls the buzz that materialized about 20 years ago over DNA vaccines, which promised the same advances as mRNA-based vaccines: quickly and cheaply made vaccines that triggered really good immune responses. But DNA vaccines didn't produce as good of an immunogenic response in humans as they did in mice during testing....